New hope for tough childhood cancer: experimental drug trial opens
NCT ID NCT06622941
Summary
This study is testing an experimental drug called ONO4538 in patients with advanced or recurrent rhabdoid tumors, a rare and aggressive cancer. It is for people aged 1 year and older whose cancer has not responded to or has come back after standard chemotherapy. The main goal is to see if the drug can shrink tumors and to check how safe it is for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHABDOID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hokkaido University Hospital
RECRUITINGSapporo, Hokkaido, 060-8648, Japan
-
Hyogo Prefectural Kobe Children's Hospital
RECRUITINGKobe, Hyōgo, Japan
-
Nagoya University Hospital
RECRUITINGNagoya, Aichi-ken, Japan
-
National Cancer Center Hospital
RECRUITINGChuo-ku, Tokyo, Japan
-
Osaka City General Hospital
RECRUITINGOsaka, Osaka, Japan
Conditions
Explore the condition pages connected to this study.